Rapid development of an evidence- and consensus-based guideline for controlling transmission of SARS-CoV-2 in schools during a public health emergency - A process evaluation.
Evidence-to-Decision framework
WHO-INTEGRATE
evidence
expertise
public health guideline
rapid guideline
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
20
10
2022
accepted:
09
03
2023
medline:
18
4
2023
entrez:
17
4
2023
pubmed:
18
4
2023
Statut:
epublish
Résumé
Different measures to prevent and control the spread of SARS-CoV-2 have been implemented in German schools. Decisions regarding such measures should be informed by evidence regarding their effectiveness, and their unintended consequences for health and society. A multi-stakeholder panel was convened to develop an evidence- and consensus-based guideline for school measures, using the novel WHO-INTEGRATE framework. Developing a guideline to inform decision-making outside of the clinical realm during a public health emergency was unprecedented in Germany. This study aims to identify lessons learnt for similar endeavours by addressing the following research question: What were the strengths and weaknesses of the guideline development process as perceived by the different groups involved? Fifteen semi-structured interviews were conducted virtually. We recruited participants aiming to include the perspectives of all groups contributing to the guideline development, including both panel members (scientists, practitioners, school family and observers) and the guideline secretariat. For analysis, we carried out deductive-inductive thematic qualitative text analysis according to Kuckartz, structuring findings using a category system. Due to time pressure, the guideline secretariat was heavily involved not only in synthesising the evidence but also in developing and drafting recommendations. Participants critically reflected on certain methods-related decisions, including the development of draft recommendations and application of the WHO-INTEGRATE framework by scientists only. The full potential of the framework might not have been harnessed. Participants' understanding of relevant and valid evidence varied, and the available evidence base was limited. Participants represented different types of expertise, notably expertise informed by scientific evidence and expertise grounded in lived experience, influencing their involvement in the guideline development process and discussions during meetings. Developing an evidence- and consensus-based public health guideline in only three months was challenging, notably because of the involvement of a broad range of stakeholders and the use of a novel Evidence-to-Decision framework, both unprecedented in Germany. Learning from this process with a view to "institutionalising" the development of public health guidelines and refining methods can contribute to more evidence-informed public health decision-making in Germany and beyond, in general and during a public health emergency.
Identifiants
pubmed: 37064706
doi: 10.3389/fpubh.2023.1075210
pmc: PMC10097910
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1075210Informations de copyright
Copyright © 2023 Wabnitz, Rueb, Pfadenhauer, Strahwald and Rehfuess.
Déclaration de conflit d'intérêts
EAR, BS, and LMP are members of the guideline secretariat as well as initiators of this process evaluation, which represents a conflict of interest (see Methods and Discussion with regard to how this research sought to minimise any undue influence as a result of this conflict of interest). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Evid Based Med. 2018 Aug;11(3):133-135
pubmed: 30094943
BMJ Open. 2021 Aug 17;11(8):e053371
pubmed: 34404718
Health Res Policy Syst. 2006 Nov 29;4:15
pubmed: 17134482
Cochrane Database Syst Rev. 2022 Jan 17;1:CD015029
pubmed: 35037252
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000844
pubmed: 30775012
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Cochrane Database Syst Rev. 2022 Jun 6;6:CD015397
pubmed: 35661990
Environ Int. 2016 Jul-Aug;92-93:585-9
pubmed: 27126781
BMJ. 2019 Jul 19;366:l4606
pubmed: 31324659
Front Psychol. 2021 Sep 16;12:746289
pubmed: 34603162